Dr. Frohlich's specialty is medical biochemistry, which is a subspecialty of Pathology and Laboratory Medicine. Over the last 25 years he has further sub-specialized into laboratory and clinical aspects of lipoprotein metabolism and atherosclerosis. Currently, he is the Director of the Lipid Clin...
Dr. Frohlich's specialty is medical biochemistry, which is a subspecialty of Pathology and Laboratory Medicine. Over the last 25 years he has further sub-specialized into laboratory and clinical aspects of lipoprotein metabolism and atherosclerosis. Currently, he is the Director of the Lipid Clinic and Academic Director of the Healthy Heart Program at St. Paul's Hospital.
Dr. Frohlich's current areas of active research are dyslipidemias, atherosclerosis, phytosterols in medicine, genetic determinants of response to inflammation and atherosclerosis, and HDL metabolism as well as a clinical trial of new lipid lowering medications.